Covid task force okays anti-malaria drug hydroxychloroquine for high-risk patients, with strict riders
Posted by
www.biotecnika.org
This procedure has been okayed by Drug Controller General of India
(DCGI) for "restricted use in emergency situations". The point to note
here is that this recommendation is only for high-risk cases, and not
for general use and one must not self-administer. The instructions are
clear as to who all can be put under this.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-covid-task-force-recommends-hydroxychloroquine-for-high-risk-patients-with-strict-riders/articleshow/74774540.cms
Subscribe to:
Post Comments (Atom)
Post a Comment